Sex difference in risk of torsade de pointes with d,l-sotalol.

BACKGROUND The present study was undertaken to test the hypothesis that women are more prone than men to develop torsade de pointes (TdP) in a defined cohort of patients exposed to the QT-prolonging antiarrhythmic drug d,l-sotalol. METHODS AND RESULTS In a database derived from 22 clinical trials involving 3135 adult patients who received oral d,l-sotalol (median follow-up, 164 days), TdP developed in 44 (1.9%) of 2336 men and in 33 (4.1%) of 799 women (P < .001). Logistic regression analysis identified female sex (P < .0001), presenting arrhythmia of sustained ventricular tachycardia or fibrillation (P < .0001), history of congestive heart failure (P < .001), and d,l-sotalol dose > 320 mg/d (P < .001) as factors most predictive of TdP; in addition to these, a serum creatinine > 1.4 mg/dL in women and > 1.6 mg/dL in men was weakly predictive (P < .05). After adjustment for these risk factors, women had threefold greater odds of developing TdP than men. The sex difference in TdP risk was age independent and could not be explained by differential dose-related bradycardic responses in women versus men. CONCLUSIONS Women are at increased risk of developing TdP during-administration of d,l-sotalol. This finding needs to be taken into account, together with other TdP risk factors, when patients are treated with this antiarrhythmic agent. Given the consistency between the present and other recent observations, greater caution in women regarding use of QT-prolonging drugs, in general, is advisable.

[1]  R. Glazer,et al.  Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. , 1996, Circulation.

[2]  M. Lehmann,et al.  Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender. , 1996, American heart journal.

[3]  S le Cessie,et al.  Risk of cardiac events in family members of patients with long QT syndrome. , 1995, Journal of the American College of Cardiology.

[4]  M. Lehmann,et al.  Increased Propensity of Women to Develop Torsades de Pointes During Complete Heart Block , 1995, Journal of cardiovascular electrophysiology.

[5]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs , 1993 .

[6]  D. Roden,et al.  Usefulness of sotalol for life-threatening ventricular arrhythmias. , 1993, The American journal of cardiology.

[7]  R. Davies,et al.  Clinical safety profile of sotalol in the treatment of arrhythmias. , 1993, The American journal of cardiology.

[8]  B. Singh,et al.  Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents. , 1993, The American journal of cardiology.

[9]  J. Mason.  A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. , 1993, The New England journal of medicine.

[10]  J. Hanyok.  Clinical pharmacokinetics of sotalol. , 1993, The American journal of cardiology.

[11]  R. Prineas,et al.  Sex differences in the evolution of the electrocardiographic QT interval with age. , 1992, The Canadian journal of cardiology.

[12]  Mark Keating.  Linkage Analysis and Long QT Syndrome: Using Genetics to Study Cardiovascular Disease , 1992, Circulation.

[13]  J. Horowitz,et al.  Sotalol-induced torsade de pointes: management with magnesium infusion. , 1992, Postgraduate medical journal.

[14]  K. Hashiba.  Sex Differences in Phenotypic Manifestation and Gene Transmission in the Romano‐Ward Syndrome , 1992, Annals of the New York Academy of Sciences.

[15]  M. Copass,et al.  Community-based interventions for sudden cardiac death. Impact, limitations, and changes. , 1992, Circulation.

[16]  A J Moss,et al.  Clinical features of the idiopathic long QT syndrome. , 1992, Circulation.

[17]  A. Moss,et al.  The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[18]  J. Jalife,et al.  Cardiac Electrophysiology: From Cell to Bedside , 1990 .

[19]  T. Denton,et al.  Comprehensive electrocardiology : theory and practice in health and disease , 1990 .

[20]  A. J. Camm,et al.  Sotalol for paroxysmal supraventricular tachycardias. , 1990, The American journal of cardiology.

[21]  E. Aliot,et al.  The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. , 1988, Progress in cardiovascular diseases.

[22]  J. Bourke,et al.  Arrhythmogenic effects of antiarrhythmic drugs. , 1987, European heart journal.

[23]  D. Roden,et al.  Concentration-dependent pharmacologic properties of sotalol. , 1986, The American journal of cardiology.

[24]  B F Hoffman,et al.  Action Potential Prolongation and Induction of Abnormal Automaticity by Low Quinidine Concentrations in Canine Purkinje Fibers Relationship to Potassium and Cycle Length , 1985, Circulation research.

[25]  S. Swiryn,et al.  Torsade de pointes due to quinidine: observations in 31 patients. , 1984, American heart journal.

[26]  K. Kuck,et al.  Sotalol-induced torsade de pointes. , 1984, American heart journal.

[27]  G. Kay,et al.  Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. , 1983, Journal of the American College of Cardiology.

[28]  J. Boelaert,et al.  Should clearance be normalised to body surface or to lean body mass? , 1981, British journal of clinical pharmacology.

[29]  W. M. Smith,et al.  "Les torsades de pointes": an unusual ventricular arrhythmia. , 1980, Annals of internal medicine.

[30]  K. Hashiba.  Hereditary QT prolongation syndrome in Japan: genetic analysis and pathological findings of the conducting system. , 1978, Japanese circulation journal.

[31]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[32]  B. Surawicz,et al.  The duration of the Q-U interval and its components in electrocardiograms of normal persons. , 1953, American heart journal.

[33]  H. Bazett,et al.  AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS. , 1997 .